Removal of Carbapenem-Resistant Enterobacteriaceae (CRE) from Blood by Heparin-Functional Hemoperfusion Media
Open Access
- 3 December 2014
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (12) , e114242
Abstract
Bloodstream infections due to Carbapenem-Resistant Enterobacteriaceae (CRE) are becoming more frequent and are associated with a high mortality. At present, combination antimicrobial therapy yields the best outcomes, but treatment options are limited. Many bacteria utilize heparan sulfate to bind to human cells. We studied the ability of a biomimetic device composed of polyethylene beads with endpoint-attached heparin to bind both sensitive and (CRE) E. coli and Klebsiella pneumoniae from spiked blood samples. Greater than 90% of susceptible, E. coli, CRE E. coli and CRE Klebsiella were removed by the beads. Future studies in human bacteremia with this technology are planned.Keywords
This publication has 9 references indexed in Scilit:
- Faculty Opinions recommendation of Vital signs: carbapenem-resistant Enterobacteriaceae.2014
- Antibiotic Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae: Systematic Evaluation of the Available EvidenceAntimicrobial Agents and Chemotherapy, 2014
- Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infectionsClinical Microbiology and Infection, 2012
- Affinity Apheresis for Treatment of Bacteremia Caused by Staphylococcus aureus and/or Methicillin-Resistant S. aureus (MRSA)Journal of Microbiology and Biotechnology, 2011
- Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infectionsDiagnostic Microbiology and Infectious Disease, 2011
- Heparan Sulfate Proteoglycans in Infection2011
- Emergence of Klebsiella pneumoniae Carbapenemase-Producing BacteriaSouthern Medical Journal, 2011
- Extended-Spectrum β-Lactamase Production Is Associated with an Increase in Cell Invasion and Expression of Fimbrial Adhesins in Klebsiella pneumoniaeAntimicrobial Agents and Chemotherapy, 2008
- A New Non-Thrombogenic Surface Prepared by Selective Covalent Binding of Heparin Via a Modified Reducing Terminal ResidueBiomaterials, Medical Devices, and Artificial Organs, 1983